Post-approval studies (Phase 4)Study completedNCT00249834
What this trial is testing
Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)
Who this might be right for
Infertility
Merck KGaA, Darmstadt, Germany 166